Development and usability testing of a patient decision aid to enhance shared decision-making regarding treatment decision in type 2 diabetes
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- NL-OMON21109
- Lead Sponsor
- MSD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 270
Inclusion Criteria
Patients:
-Diagnosed type 2 diabetes
-Duration of diabetes > 1 year
-HbA1c: 7.0-10.5%
-= 40 years
-Treated in first line in step (metformin) or sept 2 (metformin + sulfonylurea) according to the NHG guidelines
Healthcare providers:
-GP, practice nurse or diabetes nurse
-Currently working in primary care
-Experience in treating adult patients with type 2 diabetes for at least 2 years
Exclusion Criteria
-Patients that are treated with other antihyperglycemic agents other than metformin and/or sulfonylurea are not included in this study
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Collect and generate patient-preference data specific for type 2 diabetes treatment in a scientific robust approach that ultimately can be used to visualize an attractive and practical patient decision aid to support the choice of glucose-lowering drugs.
- Secondary Outcome Measures
Name Time Method -To identify which items – or attributes – patients with type 2 diabetes consider to be important for decision making in type 2 diabetes glucose-lowering drug treatment<br>-To develop a shortlist of 5-15 prioritized patient preferred attributes<br>-To develop several PDA concepts and discuss their usability with patients and healthcare providers